Fazirsiran (sodium)
Fazirsiran sodium is a second-generation RNAi agent. Fazirsiran sodium consistes of a cholesterol-conjugated RNAi trigger (chol-RNAi) to selectively degrade Alpha1-antitrypsin (AAT) mRNA by RNAi and a melittin-derived peptide conjugated to N-acetylgalactosamine (NAG) formulated as the excipient EX1 to promote endosomal escape of the chol-RNAi in hepatocytes[1]. Fazirsiran sodium can be used in the study of Alpha-1 Antitrypsin Deficiency (AATD) liver disease.
Product Specifications
CAS Number
[2175009-09-1]
Product Name Alternative
ARO-AAT (sodium)
UNSPSC
12352208
Target
Small Interfering RNA (siRNA)
Type
Oligonucleotides
Related Pathways
Epigenetics
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/fazirsiran-sodium.html
Purity
93.86
Solubility
10 mM in H2O
Smiles
[Fazirsiran(sodium)]
Molecular Formula
C493H610F11N163Na43O312P43S6
Molecular Weight
15587.6 (free acid)
References & Citations
[1]Christine I Wooddell, et al. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease. JCI Insight. 2020 Jun 18;5 (12) :e135348.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Salmonella schwarzengrund Dihydroorotase (pyrC)
Recombinant Salmonella schwarzengrund Dihydroorotase (pyrC)
Recombinant Salmonella schwarzengrund Dihydroorotase (pyrC)
Recombinant Salmonella schwarzengrund Dihydroorotase (pyrC)
Recombinant Salmonella schwarzengrund Dihydroorotase (pyrC)